Cargando…

Prognostic Significance of the Pluripotency Factors NANOG, SOX2, and OCT4 in Head and Neck Squamous Cell Carcinomas

Cancer stem cells (CSCs) play major roles in tumor initiation, progression, and resistance to cancer therapy. Several CSC markers have been studied in head and neck squamous cell carcinomas (HNSCC), including the pluripotency factors NANOG, SOX2, and OCT4; however, their clinical significance is sti...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pedregal-Mallo, Daniel, Hermida-Prado, Francisco, Granda-Díaz, Rocío, Montoro-Jiménez, Irene, Allonca, Eva, Pozo-Agundo, Esperanza, Álvarez-Fernández, Mónica, Álvarez-Marcos, César, García-Pedrero, Juana M., Rodrigo, Juan Pablo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7408284/ https://www.ncbi.nlm.nih.gov/pubmed/32635524 http://dx.doi.org/10.3390/cancers12071794

Ejemplares similares

A Novel Role For Nanog As An Early Cancer Risk Marker In Patients With Laryngeal Precancerous Lesions
por: Rodrigo, Juan P., et al.
Publicado: (2017)

Lectin-Like Transcript 1 (LLT1) Checkpoint: A Novel Independent Prognostic Factor in HPV-Negative Oropharyngeal Squamous Cell Carcinoma
por: Sanchez-Canteli, Mario, et al.
Publicado: (2020)

SOX2 Expression Is an Independent Predictor of Oral Cancer Progression
por: de Vicente, Juan C., et al.
Publicado: (2019)

The Novel Role of SOX2 as an Early Predictor of Cancer Risk in Patients with Laryngeal Precancerous Lesions
por: Granda-Díaz, Rocío, et al.
Publicado: (2019)

The Differential Impact of SRC Expression on the Prognosis of Patients with Head and Neck Squamous Cell Carcinoma
por: Hermida-Prado, Francisco, et al.
Publicado: (2019)

SOX2, OCT4 and NANOG: The core embryonic stem cell pluripotency regulators in oral carcinogenesis
por: Swain, Niharika, et al.
Publicado: (2020)

Geminin Escapes Degradation in G1 of Mouse Pluripotent Cells and Mediates the Expression of Oct4, Sox2, and Nanog
por: Yang, Valerie S., et al.
Publicado: (2011)

Nanog, Oct4 and Tet1 interplay in establishing pluripotency
por: Olariu, Victor, et al.
Publicado: (2016)

Immunoexpression of stem cell markers SOX-2, NANOG AND OCT4 in ameloblastoma
por: Martins Balbinot, Karolyny, et al.
Publicado: (2023)

Characterization of SOX2, OCT4 and NANOG in Ovarian Cancer Tumor-Initiating Cells
por: Robinson, Mikella, et al.
Publicado: (2021)

SUMOylation Represses Nanog Expression via Modulating Transcription Factors Oct4 and Sox2
por: Wu, Yongyan, et al.
Publicado: (2012)

Distinctive Expression and Amplification of Genes at 11q13 in Relation to HPV Status with Impact on Survival in Head and Neck Cancer Patients
por: Hermida-Prado, Francisco, et al.
Publicado: (2018)

The Emerging Role of NANOG as an Early Cancer Risk Biomarker in Patients with Oral Potentially Malignant Disorders
por: de Vicente, Juan C., et al.
Publicado: (2019)

Autochthonous Mouse Melanoma and Mammary Tumors do not Express the Pluripotency Genes Oct4 and Nanog
por: Schreiber, Caroline, et al.
Publicado: (2013)

The effects of embryo splitting on Cdx2, Sox2, Oct4, and Nanog gene expression in mouse blastocysts
por: Rahbaran, M., et al.
Publicado: (2022)

Assessment of the Potential of CDK2 Inhibitor NU6140 to Influence the Expression of Pluripotency Markers NANOG, OCT4, and SOX2 in 2102Ep and H9 Cells
por: Kallas, Ade, et al.
Publicado: (2014)

Dissecting the role of distinct OCT4-SOX2 heterodimer configurations in pluripotency
por: Tapia, Natalia, et al.
Publicado: (2015)

Manganese Superoxide Dismutase Gene Expression Is Induced by Nanog and Oct4, Essential Pluripotent Stem Cells’ Transcription Factors
por: Solari, Claudia, et al.
Publicado: (2015)

Nocodazole Treatment Decreases Expression of Pluripotency Markers Nanog and Oct4 in Human Embryonic Stem Cells
por: Kallas, Ade, et al.
Publicado: (2011)

Expression of early transcription factors Oct-4, Sox-2 and Nanog by porcine umbilical cord (PUC) matrix cells
por: Carlin, Ryan, et al.
Publicado: (2006)

Culture of leukocyte-derived cells from human peripheral blood: Increased expression of pluripotent genes OCT4, NANOG, SOX2, self-renewal gene TERT and plasticity
por: Lee, Yi-Jen, et al.
Publicado: (2023)

The SRC Inhibitor Dasatinib Induces Stem Cell-Like Properties in Head and Neck Cancer Cells that are Effectively Counteracted by the Mithralog EC-8042
por: Hermida-Prado, Francisco, et al.
Publicado: (2019)

Reduced Oct4 Expression Directs a Robust Pluripotent State with Distinct Signaling Activity and Increased Enhancer Occupancy by Oct4 and Nanog
por: Karwacki-Neisius, Violetta, et al.
Publicado: (2013)

Analyzing bovine OCT4 and NANOG enhancer activity in pluripotent stem cells using fluorescent protein reporters
por: Huang, Delun, et al.
Publicado: (2018)

Embryonic Stem Cells Markers SOX2, OCT4 and Nanog Expression and Their Correlations with Epithelial-Mesenchymal Transition in Nasopharyngeal Carcinoma
por: Luo, Weiren, et al.
Publicado: (2013)

Enrichment of the embryonic stem cell reprogramming factors Oct4, Nanog, Myc, and Sox2 in benign and malignant vascular tumors
por: Amaya, Clarissa N., et al.
Publicado: (2015)

Expression of SOX2, NANOG and OCT4 in a mouse model of lipopolysaccharide-induced acute uterine injury and intrauterine adhesions
por: Xiao, Li, et al.
Publicado: (2017)

Relative Expression of OCT4, SOX2 and NANOG in Oral Squamous Cell Carcinoma Versus Adjacent Non- Tumor Tissue
por: Baghai Naini, Fereshteh, et al.
Publicado: (2019)

Nanog Is the Gateway to the Pluripotent Ground State
por: Silva, Jose, et al.
Publicado: (2009)

Correction: Embryonic Stem Cells Markers SOX2, OCT4 and Nanog Expression and Their Correlations with Epithelial-Mesenchymal Transition in Nasopharyngeal Carcinoma
por: Luo, Weiren, et al.
Publicado: (2013)

The prognostic value of whole blood SOX2, NANOG and OCT4 mRNA expression in advanced small-cell lung cancer
por: Sodja, Eva, et al.
Publicado: (2016)

Correlation of Cancer Stem-Cell Markers OCT4, SOX2, and NANOG with Clinicopathological Features and Prognosis in Operative Patients with Rectal Cancer
por: You, Liuping, et al.
Publicado: (2018)

Pathobiological functions and clinical implications of annexin dysregulation in human cancers
por: Prieto-Fernández, Llara, et al.
Publicado: (2022)

Impact of PI3K/AKT/mTOR pathway activation on the prognosis of patients with head and neck squamous cell carcinomas
por: García-Carracedo, Darío, et al.
Publicado: (2016)

Factors Secreted by Cancer-Associated Fibroblasts that Sustain Cancer Stem Properties in Head and Neck Squamous Carcinoma Cells as Potential Therapeutic Targets
por: Álvarez-Teijeiro, Saúl, et al.
Publicado: (2018)

SOX2 Is Regulated Differently from NANOG and OCT4 in Human Embryonic Stem Cells during Early Differentiation Initiated with Sodium Butyrate
por: Kallas, Ade, et al.
Publicado: (2014)

Bright/Arid3A Acts as a Barrier to Somatic Cell Reprogramming through Direct Regulation of Oct4, Sox2, and Nanog
por: Popowski, Melissa, et al.
Publicado: (2014)

Identification and characterisation of NANOG+/ OCT-4(high)/SOX2+ doxorubicin-resistant stem-like cells from transformed trophoblastic cell lines
por: Balahmar, Reham M., et al.
Publicado: (2018)

Evaluation of the Effect of Orlistatorlistat on Expression of OCT4, Nanog, SOX2, and KLF4 Genes in Colorectal Cancer SW40 Cell Line
por: Noroozi Karimabad, Mojgan, et al.
Publicado: (2021)

Endogenous fluctuations of OCT4 and SOX2 bias pluripotent cell fate decisions
por: Strebinger, Daniel, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_c5m269rgfn0oe9lvje110gt03t